About Nicholas Boyd
Form D filings for Escalante Bioscience in 2024 list Nicholas Boyd as director.
Nicholas Boyd first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Nicholas Boyd in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nicholas Boyd works with at each company, as listed on that company's latest Form D.
Escalante Bioscience, Inc. · Form D, May 17, 2024
AT
Akshay Tambe
Director
AS
April Schleck
Executive officer and director
CH
Ching-Yun Hsu
Chief Executive Officer and director